Overview of Prostate Cancer Therapeutics Market in Global Industry : Share, Trends, Insight and Application 2017

ResearchMoz presents professional and in-depth study of "Prostate Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024".

This report on the prostate cancer therapeutics market analyzes the current and future scenario of the global market. Increasing prevalence of prostate cancer, launch of promising emerging therapies, as well as innovation in the development of new drugs & therapeutic biological products, and high growth in hormone-refractory prostate cancer drug due to lesser side effects are some of the drivers expected to drive the global prostate cancer therapeutics market during the forecast period.

The global prostate cancer therapeutics market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the country’s market with respect to the segments based on therapy type, distribution channels and regions. A detailed qualitative analysis of drivers and restraints, opportunities, and trends has been provided in the market overview section. Additionally, the section comprises Porters Five Forces Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of country and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global prostate cancer therapeutics market.

Global Prostate Cancer Therapeutics Market: Key Segments

Based on therapy type, the market has been segmented into hormone therapy, chemotherapy, biologic therapy and targeted therapy. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference from oncologists for treating the prostate cancer with various drug classes. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Based on distribution channels, the global prostate cancer therapeutics market has been segmented into hospital pharmacy, retail pharmacy, online sales and others. The market segments have been extensively analyzed based on increase in demand for disease treatment among prostate cancer patients. Increased patient hospitalization for the treatment of prostate cancer are driving the market share of hospital pharmacy segment. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=1064481

Global Prostate Cancer Therapeutics Market: Regional Outlook

Geographically, the global prostate cancer therapeutics market on the basis of region has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Companies Mentioned in Report

The report also profiles major players in the global prostate cancer therapeutics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include players in the global prostate cancer therapeutics market are Amgen, Inc., Johnson & Johnson (Janssen Biotech, Inc.), Pfizer, Inc., AstraZeneca, AbbVie, Inc., Bayer AG, Ipsen Group, Sanofi, Endo Pharmaceuticals, Inc., Dendreon Corporation (Sanpower Group Co. Ltd.) and others.

The Global Prostate Cancer Therapeutics Market is segmented as given below:

Global Prostate Cancer Therapeutics Market, by Therapy

    Hormone Therapy
    Luteinizing Hormone-Releasing Hormone Analogs
    Luteinizing Hormone-Releasing Hormone Antagonists
    Antiandrogens
    Chemotherapy
    Systemic Chemotherapy
    Regional Chemotherapy
    Biologic Therapy
    Targeted Therapy

Global Prostate Cancer Therapeutics Market, by Distribution Channel

    Hospital Pharmacy
    Retail Pharmacy
    Online Sales
    Others

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1064481

Global Prostate Cancer Therapeutics Market, by Geography

    North America
    U.S.
    Canada
    Europe
    Germany
    U.K.
    Italy
    France
    Spain
    Russia
    Rest of Europe
    Asia Pacific
    Japan
    India
    China
    Australia & New Zealand
    Rest of Asia Pacific
    Latin America
    Brazil
    Mexico
    Rest of Latin America
    Middle East & Africa
    Saudi Arabia
    South Africa
    UAE
    Rest of Middle East & Africa

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://researchreportlife.blogspot.in//